查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573718

心血管數位解決方案市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Cardiovascular Digital Solutions Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球心血管數位解決方案市場估值為955 億美元，預計2024 年至2032 年複合年成長率為6.1%。市場擴張。

遠距醫療的技術進步在推動市場成長方面發揮關鍵作用。這些創新不僅支持心血管疾病的監測和診斷，還滿足了對遠距醫療解決方案不斷成長的需求。穿戴式技術，包括智慧手錶和帶有心電圖感測器的健身追蹤器，正在改變心血管護理的模式。此類設備有助於持續監測心律、血壓和其他生命徵象，從而向患者和醫療保健專業人員提供即時資料。這種及時檢測異常並遠端監控健康趨勢的能力是市場成長的主要催化劑。

整個行業是應用程式、元件、部署模式、最終用途和區域。

市場按應用細分為心臟監測和診斷、CVD 健康資訊學、心臟復健計劃和其他領域。心臟監測和診斷領域佔據市場主導地位，到2023 年，其價值將達到569 億美元。疾病等流行疾病凸顯了這一點。

從部署角度來看，市場分為基於雲端的解決方案和本地解決方案。 2023 年，基於雲端的解決方案佔據了 53.2% 的主導市場。這些雲端解決方案提供了可擴展的基礎設施，使醫療保健提供者能夠無縫調整資源以回應需求波動。這種適應性對於管理不同的患者資料量和根據需要增強功能至關重要。

2023年，北美心血管數位解決方案市場估值為355億美元，預測分析期間複合年成長率為5.4%。該地區冠狀動脈疾病和高血壓等心血管疾病的高發生率刺激了對確保持續監測和複雜診斷的數位解決方案的需求。此外，北美強大的醫療基礎設施及其對數位健康技術的廣泛採用簡化了心血管數位解決方案的整合和應用。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 心臟病盛行率不斷上升
      • 遠距醫療的技術進步
      • 新產品的認知度和可近性不斷提高
      • 擴大採用資料驅動的醫療保健模式
    • 產業陷阱與挑戰
      • 資料安全問題
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 差距分析
  • 政策格局

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按應用分類，2021 - 2032 年

  • 主要趨勢
  • 心臟監測與診斷
  • 心血管疾病健康資訊學
  • 心臟復健計劃
  • 其他應用

第 6 章：市場估計與預測：按組成部分，2021 - 2032 年

  • 主要趨勢
  • 裝置
  • 軟體

第 7 章：市場估計與預測：按部署模式，2021 - 2032 年

  • 主要趨勢
  • 基於雲端
  • 本地部署

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 居家護理
  • 其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • AliveCor, Inc.
  • Apple Inc.
  • Baxter
  • Cardiac Insight, Inc.
  • Cardiotrack
  • eviCore healthcare
  • Garmin
  • GE Healthcare
  • HeartFlow
  • iRhythm Technologies, Inc.
  • Myia Health
  • Omron Healthcare
  • Qardio
  • Verily Life Sciences LLC,
  • Welch Allyn
簡介目錄
Product Code: 11047

The Global Cardiovascular Digital Solutions Market was valued at USD 95.5 billion in 2023 and is projected to grow at a CAGR of 6.1% from 2024 to 2032. The market expansion is fueled by the rising prevalence of cardiac conditions, technological strides in telehealth, and heightened awareness and accessibility of emerging products.

Telehealth's technological advancements play a pivotal role in propelling the market growth. These innovations not only bolster the monitoring and diagnosis of cardiovascular conditions but also cater to the surging demand for remote healthcare solutions. Wearable technologies, including smartwatches and fitness trackers with ECG (electrocardiogram) sensors, are transforming the landscape of cardiovascular care. Such devices facilitate the continuous monitoring of heart rhythms, blood pressure, and other vital signs for delivering real-time data to patients and healthcare professionals. This capability to detect anomalies promptly and monitor health trends remotely is a primary catalyst for the market growth.

The overall industry is application, component, deployment mode, end-use, and region.

The market is segmented by application into cardiac monitoring and diagnosis, CVD health informatics, cardiac rehab programs, and other areas. Dominating the market, the cardiac monitoring and diagnosis segment was valued at USD 56.9 billion in 2023. Given that cardiovascular diseases (CVDs) rank among the top global causes of morbidity and mortality, the prevalent conditions like hypertension, arrhythmias, and coronary artery disease underscore the demand for precise diagnostic tools and continuous monitoring.

Deployment-wise, the market is divided into cloud-based and on-premise solutions. In 2023, cloud-based solutions commanded a dominant market share of 53.2%. These cloud solutions provide a scalable infrastructure, enabling healthcare providers to adjust resources seamlessly in response to demand fluctuations. Such adaptability is vital for managing diverse patient data volumes and enhancing capabilities as required.

In 2023, North America cardiovascular digital solutions market was valued at USD 35.5 billion, with projections indicating a CAGR of 5.4% during the analysis period. The region's high prevalence of cardiovascular diseases, such as coronary artery disease and hypertension, fuels the demand for digital solutions that ensure continuous monitoring and sophisticated diagnostics. Furthermore, North America's robust healthcare infrastructure and its widespread embrace of digital health technologies streamline the integration and application of cardiovascular digital solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of cardiac conditions
      • 3.2.1.2 Technological advancements in telehealth
      • 3.2.1.3 Rising awareness and accessibility of the new products
      • 3.2.1.4 Growing adoption of data driven healthcare model
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Data security concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends
  • 3.9 GAP analysis
  • 3.10 Policy landscape

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Cardiac monitoring and diagnosis
  • 5.3 CVD health informatics
  • 5.4 Cardiac rehab programs
  • 5.5 Other applications

Chapter 6 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Devices
  • 6.3 Software

Chapter 7 Market Estimates and Forecast, By Deployment Mode, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cloud-based
  • 7.3 On-premise

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Homecare
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AliveCor, Inc.
  • 10.2 Apple Inc.
  • 10.3 Baxter
  • 10.4 Cardiac Insight, Inc.
  • 10.5 Cardiotrack
  • 10.6 eviCore healthcare
  • 10.7 Garmin
  • 10.8 GE Healthcare
  • 10.9 HeartFlow
  • 10.10 iRhythm Technologies, Inc.
  • 10.11 Myia Health
  • 10.12 Omron Healthcare
  • 10.13 Qardio
  • 10.14 Verily Life Sciences LLC,
  • 10.15 Welch Allyn